In vitro prediction of drug-induced cholestatic liver injury: a challenge for the toxicologist.
作者信息
Vinken Mathieu
机构信息
Department of In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090, Brussels, Belgium.
出版信息
Arch Toxicol. 2018 May;92(5):1909-1912. doi: 10.1007/s00204-018-2201-4. Epub 2018 Mar 24.
Abstract
摘要
相似文献
1
In vitro prediction of drug-induced cholestatic liver injury: a challenge for the toxicologist.药物性胆汁淤积性肝损伤的体外预测：毒理学家面临的一项挑战。
Arch Toxicol. 2018 May;92(5):1909-1912. doi: 10.1007/s00204-018-2201-4. Epub 2018 Mar 24.
2
Drug-induced cholestasis.药物性胆汁淤积。
Clin Liver Dis. 2013 Nov;17(4):519-31, vii. doi: 10.1016/j.cld.2013.07.015.
3
Mechanisms and in vitro models of drug-induced cholestasis.药物性胆汁淤积的机制和体外模型。
Arch Toxicol. 2019 May;93(5):1169-1186. doi: 10.1007/s00204-019-02437-2. Epub 2019 Apr 10.
4
Risk factors for development of cholestatic drug-induced liver injury: inhibition of hepatic basolateral bile acid transporters multidrug resistance-associated proteins 3 and 4.导致胆汁淤积性药物性肝损伤的风险因素：胆汁酸肝基底外侧转运体多药耐药相关蛋白 3 和 4 的抑制。
Drug Metab Dispos. 2014 Apr;42(4):665-74. doi: 10.1124/dmd.113.054304. Epub 2013 Oct 23.
5
[Acute cholestatic hepatitis induced by glimepiride].[格列美脲诱发的急性胆汁淤积性肝炎]
Gastroenterol Clin Biol. 2000 Dec;24(12):1233-4.
6
Inter-individual differences in the susceptibility of primary human hepatocytes towards drug-induced cholestasis are compound and time dependent.个体间原发性人肝细胞对药物诱导的胆汁淤积易感性的差异是复杂的且具有时间依赖性。
Toxicol Lett. 2018 Oct 1;295:187-194. doi: 10.1016/j.toxlet.2018.06.1069. Epub 2018 Jun 18.
7
Testing in vitro tools for the prediction of cholestatic liver injury induced by non-pharmaceutical chemicals.用于预测非药物化学品引起的胆汁淤积性肝损伤的体外工具测试。
Food Chem Toxicol. 2021 Jun;152:112165. doi: 10.1016/j.fct.2021.112165. Epub 2021 Apr 2.
8
Swertia cincta and its main active ingredients regulate the PPAR-α pathway in anti-cholestatic liver injury.獐牙菜及其主要活性成分在抗胆汁淤积性肝损伤中调节过氧化物酶体增殖物激活受体α（PPAR-α）信号通路。
J Ethnopharmacol. 2025 Jan 30;337(Pt 3):118956. doi: 10.1016/j.jep.2024.118956. Epub 2024 Oct 17.
9
Flucloxacillin and cholestatic hepatitis.氟氯西林与胆汁淤积性肝炎
Med J Aust. 1994 Apr 18;160(8):525.
10
Drug-induced cholestasis.药物性胆汁淤积。
Hepatology. 2011 Apr;53(4):1377-87. doi: 10.1002/hep.24229.
引用本文的文献
1
Identification of reversible OATP1B1 and time-dependent CYP3A4 inhibition as the major risk factors for drug-induced cholestasis (DIC).鉴定出 OATP1B1 的可逆转性和 CYP3A4 的时间依赖性抑制作用是导致药物性胆汁淤积（DIC）的主要危险因素。
Arch Toxicol. 2024 Oct;98(10):3409-3424. doi: 10.1007/s00204-024-03794-3. Epub 2024 Jul 18.
2
Formation of functional, extended bile canaliculi, and increased bile acid production in sandwich-cultured human cryopreserved hepatocytes using commercially available culture medium.使用市售培养基在三明治培养的人冷冻保存肝细胞中形成功能性、扩展的胆小管和增加胆汁酸产生。
Arch Toxicol. 2024 Aug;98(8):2605-2617. doi: 10.1007/s00204-024-03757-8. Epub 2024 May 16.
3
Unraveling the mechanisms underlying drug-induced cholestatic liver injury: identifying key genes using machine learning techniques on human in vitro data sets.阐明药物性胆汁淤积性肝损伤的机制：使用人类体外数据集上的机器学习技术鉴定关键基因。
Arch Toxicol. 2023 Nov;97(11):2969-2981. doi: 10.1007/s00204-023-03583-4. Epub 2023 Aug 21.
4
Cholestasis: exploring the triangular relationship of gut microbiota-bile acid-cholestasis and the potential probiotic strategies.胆汁淤积症：探索肠道微生物群-胆汁酸-胆汁淤积症的三角关系及潜在的益生菌策略。
Gut Microbes. 2023 Jan-Dec;15(1):2181930. doi: 10.1080/19490976.2023.2181930.
5
Role of Hepatocyte Transporters in Drug-Induced Liver Injury (DILI)-In Vitro Testing.肝细胞转运体在药物性肝损伤（DILI）体外检测中的作用
Pharmaceutics. 2022 Dec 22;15(1):29. doi: 10.3390/pharmaceutics15010029.
6
Population pharmacokinetic model to generate mechanistic insights in bile acid homeostasis and drug-induced cholestasis.用于生成胆汁酸动态平衡和药物性胆汁淤积的机制见解的群体药代动力学模型。
Arch Toxicol. 2022 Oct;96(10):2717-2730. doi: 10.1007/s00204-022-03345-8. Epub 2022 Jul 25.
7
Proteomic profiling of murine biliary-derived hepatic organoids and their capacity for drug disposition, bioactivation and detoxification.鼠胆管源性肝类器官的蛋白质组学分析及其在药物处置、生物活化和解毒中的作用。
Arch Toxicol. 2021 Jul;95(7):2413-2430. doi: 10.1007/s00204-021-03075-3. Epub 2021 May 29.
8
Predicting Drug-Induced Liver Injury Using Convolutional Neural Network and Molecular Fingerprint-Embedded Features.使用卷积神经网络和分子指纹嵌入特征预测药物性肝损伤
ACS Omega. 2020 Sep 22;5(39):25432-25439. doi: 10.1021/acsomega.0c03866. eCollection 2020 Oct 6.
9
Protective effects of catalpol on mitochondria of hepatocytes in cholestatic liver injury.梓醇对胆汁淤积性肝损伤肝细胞线粒体的保护作用。
Mol Med Rep. 2020 Sep;22(3):2424-2432. doi: 10.3892/mmr.2020.11337. Epub 2020 Jul 13.
10
Differential toxic effects of bile acid mixtures in isolated mitochondria and physiologically relevant HepaRG cells.胆汁酸混合物对分离的线粒体和生理相关 HepaRG 细胞的毒性作用差异。
Toxicol In Vitro. 2019 Dec;61:104595. doi: 10.1016/j.tiv.2019.104595. Epub 2019 Jul 6.
本文引用的文献
1
An Update on Adverse Outcome Pathways Leading to Liver Injury.导致肝损伤的不良结局途径的最新进展
Appl In Vitro Toxicol. 2017 Dec 1;3(4):283-285. doi: 10.1089/aivt.2017.0027. Epub 2017 Dec 6.
2
Adverse outcome pathways: opportunities, limitations and open questions.不良结局途径：机遇、局限性和未解决问题。
Arch Toxicol. 2017 Nov;91(11):3477-3505. doi: 10.1007/s00204-017-2045-3. Epub 2017 Oct 19.
3
Adverse outcome pathways: a concise introduction for toxicologists.不良结局途径：毒理学家简明指南。
Arch Toxicol. 2017 Nov;91(11):3697-3707. doi: 10.1007/s00204-017-2020-z. Epub 2017 Jun 28.
4
Penicillinase-resistant antibiotics induce non-immune-mediated cholestasis through HSP27 activation associated with PKC/P38 and PI3K/AKT signaling pathways.青霉素酶抗性抗生素通过 HSP27 激活诱导非免疫介导的胆汁淤积，该激活与 PKC/P38 和 PI3K/AKT 信号通路有关。
Sci Rep. 2017 May 12;7(1):1815. doi: 10.1038/s41598-017-01171-y.
5
The role of Kupffer cells in hepatic diseases.库普弗细胞在肝脏疾病中的作用。
Mol Immunol. 2017 May;85:222-229. doi: 10.1016/j.molimm.2017.02.018. Epub 2017 Mar 15.
6
Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory response.胆汁酸通过触发肝细胞特异性炎症反应引发胆汁淤积性肝损伤。
JCI Insight. 2017 Mar 9;2(5):e90780. doi: 10.1172/jci.insight.90780.
7
Evaluation of transcriptomic signature as a valuable tool to study drug-induced cholestasis in primary human hepatocytes.评价转录组特征作为研究原代人肝细胞中药物性胆汁淤积的有价值工具。
Arch Toxicol. 2017 Aug;91(8):2879-2893. doi: 10.1007/s00204-017-1930-0. Epub 2017 Feb 10.
8
Generation of a bile salt export pump deficiency model using patient-specific induced pluripotent stem cell-derived hepatocyte-like cells.利用患者特异性诱导多能干细胞衍生的肝细胞样细胞生成胆汁盐输出泵缺陷模型。
Sci Rep. 2017 Feb 2;7:41806. doi: 10.1038/srep41806.
9
Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell-Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury.作为药物性肝损伤预测性体外系统的干细胞衍生肝细胞、HepaRG细胞和三维人肝细胞球状体的转录、功能及机制比较
Drug Metab Dispos. 2017 Apr;45(4):419-429. doi: 10.1124/dmd.116.074369. Epub 2017 Jan 30.
10
Integrative "-Omics" Analysis in Primary Human Hepatocytes Unravels Persistent Mechanisms of Cyclosporine A-Induced Cholestasis.原代人肝细胞中的整合“组学”分析揭示了环孢素A诱导胆汁淤积的持续机制。
Chem Res Toxicol. 2016 Dec 19;29(12):2164-2174. doi: 10.1021/acs.chemrestox.6b00337. Epub 2016 Dec 2.
Zotero 插件